1. Home
  2. TRTX vs CRMD Comparison

TRTX vs CRMD Comparison

Compare TRTX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TPG RE Finance Trust Inc.

TRTX

TPG RE Finance Trust Inc.

HOLD

Current Price

$8.05

Market Cap

660.2M

Sector

Real Estate

ML Signal

HOLD

Logo CorMedix Inc.

CRMD

CorMedix Inc.

HOLD

Current Price

$8.07

Market Cap

590.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRTX
CRMD
Founded
2014
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
660.2M
590.7M
IPO Year
2015
2009

Fundamental Metrics

Financial Performance
Metric
TRTX
CRMD
Price
$8.05
$8.07
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$9.83
$14.83
AVG Volume (30 Days)
835.2K
884.7K
Earning Date
04-28-2026
05-11-2026
Dividend Yield
11.55%
N/A
EPS Growth
N/A
780.00
EPS
0.19
0.43
Revenue
N/A
$311,709,000.00
Revenue This Year
$8.78
$0.30
Revenue Next Year
$4.14
N/A
P/E Ratio
$41.84
$16.58
Revenue Growth
N/A
617.03
52 Week Low
$7.57
$6.13
52 Week High
$9.85
$14.96

Technical Indicators

Market Signals
Indicator
TRTX
CRMD
Relative Strength Index (RSI) 42.48 54.63
Support Level $8.04 $7.09
Resistance Level $8.74 $9.02
Average True Range (ATR) 0.19 0.35
MACD -0.02 0.03
Stochastic Oscillator 17.50 48.67

Price Performance

Historical Comparison
TRTX
CRMD

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Share on Social Networks: